shopify analytics ecommerce
Motif Bio plcMotif Bio plc
  • Home
  • About
    • About Motif
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Scientific and Commercial Team
    • Careers
  • Development Programs
    • Pipeline Overview
    • Iclaprim
    • Publications
  • Partnering
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Details
    • Financial Reports
    • Corporate Governance
    • AIM Investors
    • Investor FAQs
    • Investor Resources
  • Contact
  • No menu assigned!

SEC Filings

Form SC 13G
MOTIF BIO PLC filed this Form SC 13G on 02/05/2019
Document Outline
Entire Document (28.1 KB)
Subdocument 1 - SC 13G - MOTIF BIO PLC
Page 1 - UNITED STATES
Page 2 - G62924108
Page 3 - Item 1.
Page 4 - Item 4. Ownership.
Page 5 - SIGNATURE

Navigation

  • Overview
  • News Releases
  • Events & Presentations
  • Stock Details
  • Financial Reports
    • SEC Filings
    • Annual Reports
  • Corporate Governance
  • AIM Investors
  • Investor FAQs
  • Investor Resources
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | E-mail Alerts Email Alerts | IR Contacts IR Contact | Financial Tear Sheet Financial Tear Sheet

About Us

Motif Bio is a clinical stage biopharmaceutical company developing novel antibiotics to treat patients with serious and life-threatening infections caused by multi-drug resistant bacteria.

Recent News

Motif Bio Conference Call and Webcast
February 19, 2019
Motif BioSciences Enters into Amendment Agreement with Hercules Capital
February 18, 2019
Motif Bio Receives Complete Response Letter from the FDA
February 14, 2019

Navigation

  • About Motif
  • Iclaprim
  • Investors
  • News Releases
  • Contact Us

Contact Us

Motif Bio plc
201 Temple Chambers
3-7 Temple Avenue
London EC4Y 0DT
United Kingdom

Motif BioSciences Inc.
125 Park Avenue, 25th Floor
New York, NY 10017
United States
General: info@motifbio.com
Investors: ir@motifbio.com

© 2017 Motif Bio | Disclaimer & Terms of Use

    • Home
    • About
      • About Motif
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
      • Scientific and Commercial Team
      • Careers
    • Product Programs
      • Pipeline Overview
      • Iclaprim
      • Publications
    • Opportunity
    • Investors
      • Overview
      • News Releases
      • Events & Presentations
        • Events Calendar
        • Presentations
      • Stock Details
        • Stock Quote and Chart
        • Analyst Coverage
      • Financial Reports
        • SEC Filings
        • Annual Reports
      • Corporate Governance
        • Overview
        • Management
        • Board of Directors
        • Committee Composition
        • Contact the Board
      • AIM Investors
      • Investor FAQs
      • Investor Resources
        • IR Contact
        • Email Alerts
    • Contact